Basic information Description Source Background Safety Supplier Related

Interleukin-25

Basic information Description Source Background Safety Supplier Related

Interleukin-25 Basic information

Product Name:
Interleukin-25
Synonyms:
  • ANTI-IL25 (CENTER) antibody produced in rabbit
  • Interleukin-25
  • IL25
  • IL17E
  • IL-17E from rat
  • SF-20 from mouse
  • InterleukinE
  • IL-17E human
MW:
0
Mol File:
Mol File
More
Less

Interleukin-25 Chemical Properties

storage temp. 
-20°C
form 
lyophilized
color 
white
biological source
mouse
More
Less

Safety Information

WGK Germany 
3
More
Less

Interleukin-25 Usage And Synthesis

General Description

IL-17E is a disulfide-linked homodimer of two 145 amino acid polypeptide chains. It belongs to the IL-17 family of structurally-related cytokines that share a highly conserved C-terminal region, but differ from one another in their N-terminal regions and in their distinct biological roles. The six known members of this family, IL-17A through IL-17F, are secreted as homodimers. IL-17E stimulated secretion of IL-8, and induces activation of the transcription factor NF-?B in cells that express the IL-17BR receptor. Recombinant human IL-17E is a 33.8 kDa disulfide-linked homodimer of two 146 amino acid polypeptide chains.

Biochem/physiol Actions

IL-17E is a disulfide-linked homodimer of two 145 amino acid polypeptide chains.

Description

Interleukin-17E Human Recombinant produced in E.Coli is a non-glycosylated disulfide-linked homodimer containing 2x145 amino acids (with an N-terminal Methionine for each chain total aa for each chain 146) and having a total predicted molecular mass of 33.7kDa.

The IL-25 Human is purified by proprietary chromatographic techniques.

Source

Escherichia Coli

Background

IL-25 also called IL-17E cytokine has a sequence similarity with IL17. IL-17E indluces NF-kappaB activation, and stimulates the production of IL-8. IL17E and IL17B are ligands for the cytokine receptor IL17BR. IL-25 is a proinflammatory cytokine favoring Th2-type immune response. The upregulation of costimulation-induced IL-17E receptors and release of cytokines and chemokines from IL-17E treated costimulated Th cells are differentially regulated by intracellular JNK, p38 MAPK and NF-kappaB activity. Blocking Iinterleukin-25 prevents airway hyperresponsiveness, a critical feature of clinical asthma. IL25 produced by innate effector eosinophils and basophils increase the allergic inflammation by enhancing the maintenance and functions of TSLP-DC activated adaptive Th2 memory cells. Over expression of IL-25 up-regulates gene expression of Th2 cytokines and induces growth retardation, jaundice, and multiorgan inflammation in a transgenic mouse model. IL-25 contributes to the induction and maintenance of eosinophilic inflammation by acting on lung fibroblasts which supports the fact that IL-17E is an important factor in asthma pathophysiology. IL-17E operates by amplifying TH2 cell-mediated allergic airway inflammation but doesn’t induce allergic inflammation in vivo.

Interleukin-25Supplier

Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Email
422450190@qq.com
Shanghai Huzhen Industrial Co., LTD
Tel
021-60345367 13916550749
Email
sales@shzbio.com
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
ACROBiosystems
Tel
13121935750
Email
jiaxin.zhao@acrobiosystems.com
ZSGB-BIO
Tel
02-400-810-9781 400810978
Email
sales@zsbio.com